Search Results

You are looking at 121 - 130 of 1,580 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines

Angela Pecoraro, Giuseppe Rosiello, Stefano Luzzago, Marina Deuker, Franciska Stolzenbach, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Alberto Briganti, Anil Kapoor, Cristian Fiori, Francesco Porpiglia, and Pierre I. Karakiewicz

data can provide further detail regarding the distribution of patient and renal cell carcinoma (RCC) characteristics within this special patient group. Based on these considerations, we reexamined patients with RCC with T1a 0- to 2-cm renal tumors to

Full access

Screening Process Failures for Hepatocellular Carcinoma

Amit G. Singal, Jorge A. Marrero, and Adam Yopp

characteristics could not be determined. Patients with Child-Pugh C cirrhosis and those with poor performance status were also excluded, because surveillance is not recommended in these patients. This study was approved by the Institutional Review Board at UT

Full access

Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Angel Qin, Songzhu Zhao, Abdul Miah, Lai Wei, Sandipkumar Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Peter G. Shields, Gregory P. Kalemkerian, Shirish M. Gadgeel, Nithya Ramnath, Bryan J. Schneider, Khaled A. Hassan, Nicholas Szerlip, Zoey Chopra, Sara Journey, Jessica Waninger, Daniel Spakowicz, David P. Carbone, Carolyn J. Presley, Gregory A. Otterson, Michael D. Green, and Dwight H. Owen

approved by the Institutional Review Boards of both institutions. Patient demographics, disease characteristics (stage, histology, genomic alterations, metastatic burden [defined as the number of metastatic organ systems involved: 1, 2, ≥2]), treatment

Full access

National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non–Small Cell Lung Cancer

Stephen R. Grant, Benjamin D. Smith, Lauren E. Colbert, Qunyh-Nhu Nguyen, James B. Yu, Steven H. Lin, and Aileen B. Chen

(1) assess the frequency of quality measure–concordant radiation for bone metastases as per NQF 1822; (2) describe variation in compliance by tumor, patient, and treatment characteristics; and (3) explore and consider the value, shortcomings, and

Full access

Factors Affecting Genetic Consultation in Adolescent and Young Adult Patients With Sarcoma

Grace E. McKay, Anna L. Zakas, Fauzia Osman, and Amanda Parkes

metastatic cancer at time of diagnosis, receipt of chemotherapy, and documentation of a genetics discussion with an oncology provider. Statistical Analysis Patient characteristics were recorded as percentages for categorical variables and as means and

Full access

Impact of a Clinical Trial Initiative on Clinical Trial Enrollment in a Multidisciplinary Prostate Cancer Clinic

Lydia T. Madsen, Deborah A. Kuban, Seungtaek Choi, John W. Davis, Jeri Kim, Andrew K. Lee, Delora Domain, Larry Levy, Louis L. Pisters, Curtis A. Pettaway, John F. Ward, Christopher Logothetis, and Karen E. Hoffman

conducted using SAS 9.2 (Cary, North Carolina). Results Patient Characteristics A total of 1370 men with localized prostate cancer were seen at the MPCC between 2004 and 2008 and subsequently received treatment at MD Anderson. The median age at

Full access

Cross-Sectional Analysis of the Associations Between Four Common Cancers and Disability

Lisa I. Iezzoni, Sowmya R. Rao, Nicole D. Agaronnik, and Areej El-Jawahri

) age at cancer diagnosis for persons with versus without preexisting disability, and (4) associations between cancer diagnosis and preexisting disability after adjusting for sociodemographic characteristics and selected risk factors. Methods Data We

Full access

Continuous Low-Irradiance Photodynamic Therapy: A New Therapeutic Paradigm

Gary S. Rogers

reported on the use of a hematoporphyrin derivative to treat a person with metastatic chest wall breast cancer. Table 1 lists the characteristics of 3 photosensitizers: porfimer sodium (Photofrin), 5-aminolevulinic acid (ALA), and mTHPC ( meso -tetra

Full access

Geographic Variations of Potentially Curative Treatments for Hepatocellular Carcinoma in the United States: A SEER-Medicare Study

En Cheng, Peiyin Hung, and Shi-Yi Wang

characteristics, and comorbidities were associated with survival among patients with HCC. Methods Data Source and Population We established a population-based retrospective cohort study using the SEER-Medicare linked database. The SEER program is an authoritative

Full access

The Right Place at the Right Time: Medical Oncology Outpatients' Perceptions of Location of End-of-Life Care

Amy Waller, Rob Sanson-Fisher, Nicholas Zdenkowski, Charles Douglas, Alix Hall, and Justin Walsh

to be able to die in the location of my choice (eg, at home, hospital, hospice, other),” with options ranging from strongly disagree to strongly agree. Sociodemographic and Clinical Characteristics: Sociodemographic and clinical characteristics